-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Cytosorbents Corp annual/quarterly Income Tax Expense (Benefit) history and growth rate from 2012 to 2024.
- Cytosorbents Corp Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $0.000.
- Cytosorbents Corp annual Income Tax Expense (Benefit) for 2024 was -$1.69M, a 108% decline from 2023.
- Cytosorbents Corp annual Income Tax Expense (Benefit) for 2023 was -$814K, a 25.5% increase from 2022.
- Cytosorbents Corp annual Income Tax Expense (Benefit) for 2022 was -$1.09M, a 48.4% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)